Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron + aprepitant vs palonosetron alone for prevention of postoperative nausea and vomiting in women using IV PCA
KCT0002433Phase 4Completed
- Sponsor
- Soonchunhyang University Seoul Hospital
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of palonosetron, aprepitant in postoperative nausea and vomiting (PONV), sponsored by Soonchunhyang University Seoul Hospital. Started Aug 2013; status: completed.
02
Drugs
palonosetronaprepitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on KCT0002433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002433.